Rehmann Capital Advisory Group Has $129,000 Stock Holdings in Everbridge Inc (NASDAQ:EVBG)

Rehmann Capital Advisory Group grew its holdings in Everbridge Inc (NASDAQ:EVBG) by 68.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,716 shares of the technology company’s stock after purchasing an additional 695 shares during the quarter. Rehmann Capital Advisory Group’s holdings in Everbridge were worth $129,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Strs Ohio acquired a new position in shares of Everbridge in the first quarter worth $30,000. Resources Investment Advisors Inc. lifted its position in shares of Everbridge by 32.7% during the 4th quarter. Resources Investment Advisors Inc. now owns 2,029 shares of the technology company’s stock worth $115,000 after purchasing an additional 500 shares during the last quarter. Bank of Montreal Can lifted its position in shares of Everbridge by 281.6% during the 4th quarter. Bank of Montreal Can now owns 706 shares of the technology company’s stock worth $40,000 after purchasing an additional 521 shares during the last quarter. New York State Common Retirement Fund lifted its position in Everbridge by 1.1% in the fourth quarter. New York State Common Retirement Fund now owns 51,687 shares of the technology company’s stock valued at $2,934,000 after acquiring an additional 563 shares during the last quarter. Finally, Mesirow Financial Investment Management Inc. lifted its position in Everbridge by 7.9% in the first quarter. Mesirow Financial Investment Management Inc. now owns 7,988 shares of the technology company’s stock valued at $599,000 after acquiring an additional 587 shares during the last quarter. 96.93% of the stock is currently owned by institutional investors and hedge funds.

EVBG traded up $0.86 during trading hours on Friday, reaching $99.22. 202,499 shares of the stock traded hands, compared to its average volume of 709,243. Everbridge Inc has a fifty-two week low of $41.94 and a fifty-two week high of $99.49. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.52. The firm has a market cap of $3.24 billion, a P/E ratio of -69.38 and a beta of 0.83. The business’s fifty day moving average price is $87.17.

Everbridge (NASDAQ:EVBG) last posted its quarterly earnings results on Monday, May 6th. The technology company reported ($0.39) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.48) by $0.09. Everbridge had a negative net margin of 30.93% and a negative return on equity of 52.04%. The company had revenue of $42.82 million for the quarter, compared to the consensus estimate of $42.23 million. During the same period last year, the firm posted ($0.17) EPS. The company’s revenue for the quarter was up 40.3% on a year-over-year basis. Analysts predict that Everbridge Inc will post -1.41 EPS for the current year.

EVBG has been the subject of a number of research reports. SunTrust Banks boosted their price target on shares of Everbridge to $100.00 and gave the company a “positive” rating in a research report on Thursday, June 20th. Credit Suisse Group lowered shares of COCA COLA AMATI/ADR from an “outperform” rating to a “neutral” rating in a research note on Thursday, June 20th. Raymond James dropped their price objective on shares of Adaptimmune Therapeutics from $16.00 to $6.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 7th. Northland Securities boosted their price target on shares of Everbridge from $83.00 to $105.00 and gave the stock an “outperform” rating in a research note on Friday, June 21st. Finally, Needham & Company LLC reiterated a “buy” rating and set a $100.00 price target (up from $85.00) on shares of Everbridge in a research note on Thursday, June 20th. Three analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company’s stock. Everbridge presently has an average rating of “Buy” and a consensus target price of $92.42.

In other news, SVP Elliot J. Mark sold 1,609 shares of Everbridge stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $75.00, for a total value of $120,675.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jaime Wallace Ellertson sold 277,000 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $81.45, for a total transaction of $22,561,650.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 435,747 shares of company stock worth $35,777,329. 2.20% of the stock is currently owned by insiders.

Everbridge Profile

Everbridge, Inc operates as a software company in the United States and internationally. The company's Critical Event Management, a software as a service based platform with various software applications that address tasks an organization has to perform to manage a critical event, including Mass Notification that enables enterprises and governmental entities to send notifications to individuals or groups to keep them informed before, during, and after natural or man-made disasters, and other emergencies; Safety Connection that enables organizations to send notifications based on last known location of an individual; Incident Management that enables organizations to automate workflows and make their communications relevant; and IT Alerting that enables IT professionals to alert and communicate with members of their teams during an IT incident or outage.

Read More: What is a Lock-Up Period?

Institutional Ownership by Quarter for Everbridge (NASDAQ:EVBG)

Receive News & Ratings for Everbridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everbridge and related companies with MarketBeat.com's FREE daily email newsletter.